Doctor profile · Federal record
Dr. Jeremy Kennedy, D.O.
Dermatology Physician (CMS: Dermatology) · Midlothian, VA
- NPI 1528022779
- Accepts Medicare
- MIPS 100.0 / 100 · 2023
- 4 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
611 Watkins Centre Pkwy Ste 350
Midlothian, VA 231144404
(804) 464-8644
fax (804) 464-8508
Credentials & registration
- NPI registered
- April 2006 — 20 yrs on file
- Profile last updated
- July 23, 2025
- Year of graduation
- 2022 — 4 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Virginia #0102209089
- Medicaid
- AZ #707257
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1528022779. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
13,941
Distinct HCPCS
10
Medicare allowed
$686,354
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 6,441 | 1,021 | $6 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 2,528 | 1,637 | $88 | |
17000 |
Destruction of precancer skin growth, 1 growth | 1,905 | 1,294 | $50 | |
11102 |
Biopsy of related skin growth, first growth | 766 | 624 | $88 | |
17110 |
Destruction of skin growth, 1-14 growths | 500 | 405 | $104 | |
11103 |
Biopsy of related skin growth, each additional growth | 353 | 200 | $49 | |
17262 |
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 289 | 197 | $147 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 227 | 193 | $55 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 150 | 105 | $164 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 150 | 150 | $109 |
In context: peer comparison
Among 1 peers in Midlothian Dermatology Physician, average services per provider: 497. This provider delivers 28× the peer median.Open Payments
Industry payments received
All-time total
$995
Transactions
47
Manufacturers
12
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 18 | $360.97 | |
| Amgen INC. | 4 | $101.79 | |
| Dermavant Sciences, INC. | 5 | $98.44 | |
| Regeneron Healthcare Solutions, INC. | 3 | $91.70 | |
| Pfizer INC. | 4 | $76.66 | |
| E.R. Squibb & Sons, L.L.C. | 3 | $61.13 | |
| Janssen Biotech, INC. | 3 | $57.00 | |
| Novartis Pharmaceuticals Corporation | 2 | $42.29 | |
| Sun Pharmaceutical Industries INC. | 2 | $36.97 | |
| Genzyme Corporation | 1 | $30.23 | |
| Arcutis Biotherapeutics, INC. | 1 | $22.60 | |
| Lilly USA, LLC | 1 | $15.65 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,416
Patients
959
Total drug cost
$35,185
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 345 | 223 | $2,590 |
| Hydrocortisone | Generic | 247 | 183 | $1,348 |
| Ketoconazole | Generic | 134 | 80 | $2,257 |
| Fluorouracil | Generic | 131 | 125 | $10,253 |
| Clobetasol Propionate | Generic | 92 | 46 | $3,462 |
| Betamethasone Dipropionate | Generic | 87 | 46 | $4,033 |
| Metronidazole | Generic | 65 | 45 | $3,853 |
| Doxycycline Hyclate | Generic | 56 | 31 | $1,129 |
| Mupirocin | Generic | 50 | 37 | $410 |
| Clindamycin Phosphate | Generic | 49 | 27 | $1,198 |
Frequently asked questions
What is Dr. Jeremy Kennedy's medical specialty?
Dr. Jeremy Kennedy practices Dermatology Physician in Midlothian, VA.
Where does Dr. Jeremy Kennedy practice?
Dr. Jeremy Kennedy practices at 611 Watkins Centre Pkwy Ste 350, Midlothian, VA 231144404. Office phone: 8044648644.
What is Dr. Jeremy Kennedy's NPI?
Dr. Jeremy Kennedy's National Provider Identifier (NPI) is 1528022779, issued by NPPES.
Does Dr. Jeremy Kennedy accept Medicare assignment?
Yes. Dr. Jeremy Kennedy accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Jeremy Kennedy commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.